206 results on '"Eye Infections, Viral epidemiology"'
Search Results
2. Ocular manifestations of COVID-19: systematic review and meta-analysis.
- Author
-
Tran E, Phu V, Xu R, Teoderascu A, Aly M, Shah N, and Malvankar-Mehta MS
- Subjects
- Humans, Pandemics, Prevalence, Eye Diseases epidemiology, Eye Diseases diagnosis, Eye Diseases etiology, COVID-19 epidemiology, COVID-19 complications, COVID-19 diagnosis, SARS-CoV-2, Eye Infections, Viral diagnosis, Eye Infections, Viral virology, Eye Infections, Viral epidemiology
- Abstract
Objective: Our study aims to build on our understanding of COVID-19 by detailing a comprehensive look at the prevalence of different ocular manifestations related to COVID-19 infection., Design: Systematic review and meta-analysis., Methods: Eligible studies published between June 20, 2021, and May 11, 2023, were retrieved from the MEDLINE, EMBASE, and CINAHL databases as well as grey literature. Covidence was used to conduct the systematic review. Duplicate records were removed, and 2 independent reviewers screened records for relevance. After screening, a risk-of-bias assessment was carried out. Data were extracted, and a meta-analysis was performed using STATA 14.0. Fixed-effects and random-effects models were computed based on heterogeneity., Results: Our meta-analysis included 43 articles with a total of 10,572 subjects. The results showed that COVID-19 patients had a significantly higher prevalence of conjunctivitis (effect size [ES] = 0.11; 95% CI, 0.07-0.15), ptosis (ES = 0.22; 95% CI, 0.15-0.30), and ophthalmoplegia (ES = 0.40; 95% CI, 0.06-0.74). Our results also indicate that COVID-19 patients have higher prevalence of cotton wool spots (ES = 0.06; 95% CI, 0.03-0.09), retinal hemorrhages (ES = 0.12; 95% CI, 0.06-0.18), and retinal vein tortuosity (ES = 0.19; 95% CI, 0.09-0.35)., Conclusion: COVID-19 can exhibit extrapulmonary manifestations, affecting both the anterior and posterior segments of the eye. Common anterior-segment findings include conjunctivitis, whereas posterior-segment findings may include cotton wool spots, retinal hemorrhages, and retinal vein tortuosity. Improving our understanding of the ocular manifestations of COVID-19 has the potential to facilitate quicker diagnosis and subsequent treatment., (Copyright © 2023 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Seasonal Hyperacute Panuveitis (SHAPU) Outbreak Amidst COVID-19 Pandemic.
- Author
-
Gurung H, Kharel Sitaula R, Karki P, Lamichhane G, Singh S, Shrestha E, Khatri A, Banstola A, Joshi P, Dahal HN, Sharma AK, Joshi SN, and Prasad Upadhaya M
- Subjects
- Humans, Male, Female, Cross-Sectional Studies, Child, Adolescent, Adult, Middle Aged, Eye Infections, Viral epidemiology, Eye Infections, Viral diagnosis, Disease Outbreaks, Child, Preschool, Young Adult, Aged, Animals, Pandemics, Moths, Acute Disease, COVID-19 epidemiology, Panuveitis epidemiology, Panuveitis diagnosis, SARS-CoV-2, Seasons
- Abstract
Purpose: To document the demographic profile of the SHAPU outbreak amidst the COVID-19 pandemic., Methods: A multicentric cross-sectional study of the 2021 SHAPU outbreak during the second phase of the COVID-19 outbreak., Results: A total of 135 patients were diagnosed with SHAPU from August to December 2021, 77 (57%) were children <16 years, males 54.8% and 34.8% had direct physical contact with white moths and 41.5% had severe type of SHAPU. Dramatic increment in the moth abundance was noted in these outbreak sites. Few cases presented with atypical ocular findings, unlike past outbreaks. Due to the ongoing COVID-19 pandemic with restrictions on travel and transportation, timely management was difficult and good visual outcome was achieved only in mild-moderate cases with an early presentation., Conclusion: The surge in the number of SHAPU patients, its occurrence in areas previously unreported, and some atypical presentation added raised suspicion of a possible link between COVID-19 and SHAPU.
- Published
- 2024
- Full Text
- View/download PDF
4. Outbreak of Rift Valley Fever Retinitis in Rwanda: Novel Imaging Findings and Response to Treatment with Corticosteroids.
- Author
-
De Clerck I
- Subjects
- Humans, Retrospective Studies, Rwanda epidemiology, Male, Female, Adult, Middle Aged, Young Adult, Multimodal Imaging, Aged, Rift Valley fever virus, Adolescent, Administration, Oral, Disease Outbreaks, Tomography, Optical Coherence methods, Visual Acuity physiology, Retinitis drug therapy, Retinitis diagnosis, Retinitis epidemiology, Retinitis virology, Fluorescein Angiography methods, Glucocorticoids therapeutic use, Rift Valley Fever epidemiology, Rift Valley Fever drug therapy, Rift Valley Fever diagnosis, Eye Infections, Viral drug therapy, Eye Infections, Viral epidemiology, Eye Infections, Viral diagnosis, Eye Infections, Viral virology
- Abstract
Purpose: To describe the clinical and epidemiological characteristics of the first epidemic of Rift Valley Fever retinitis in Rwanda and to report novel imaging findings and a possible role for corticosteroids., Methods: Retrospective analysis of all patients who presented with presumed Rift Valley Fever retinitis at the Rwanda Charity Eye Hospital over a period of 4 months in 2022. Multimodal images are reviewed including optical coherence tomography, fluorescein angiography, color, infrared, red-free, and autofluorescence photography., Results: The newly identified arciform hyporeflective pattern on infrared imaging was present in 100% of patients. Out of 9 patients treated with oral corticosteroids, 7 (78%) experienced a visual acuity increase of at least 0.2 during follow-up, in comparison to only 4 (28%) out of 14 of untreated patients. Out of four patients treated with a subtenon corticosteroid injection, only one (25%) reached this threshold. Post-hoc pairwise comparison with Bonferroni correction revealed a significant difference in average visual acuity improvement ( p = 0.034) between patients receiving oral corticosteroids (0.35 ± 0.07) versus no treatment (0.11 ± 0.04)., Conclusion: The identified arciform hyporeflective pattern on infrared imaging appears to be characteristic of Rift Valley Fever retinitis and should be known to clinicians working in endemic regions. Compared to a historical cohort and to untreated patients in this non-randomized study, there appears to be a benefit of treatment with oral corticosteroids.
- Published
- 2024
- Full Text
- View/download PDF
5. Prevalence, Patterns, and Predictors of SARS-CoV-2 RNA and Culturable Virus in Tears of a Case-Ascertained Household Cohort.
- Author
-
So M, Goldberg SA, Lu S, Garcia-Knight M, Davidson MC, Tassetto M, Murray VW, Anglin K, Pineda-Ramirez J, Chen JY, Rugart PR, Richardson ET, Briggs-Hagen M, Midgley CM, Andino R, Seitzman GD, Gonzales J, Peluso MJ, Martin JN, and Kelly JD
- Subjects
- Humans, Male, Female, Prospective Studies, Prevalence, Adult, Middle Aged, Cross-Sectional Studies, COVID-19 Nucleic Acid Testing, Eye Infections, Viral virology, Eye Infections, Viral epidemiology, Eye Infections, Viral diagnosis, Family Characteristics, Aged, Longitudinal Studies, COVID-19 epidemiology, COVID-19 virology, COVID-19 diagnosis, SARS-CoV-2 genetics, RNA, Viral genetics, RNA, Viral analysis, Tears virology
- Abstract
Purpose: To investigate the prevalence, patterns, and predictors of SARS-CoV-2 RNA and culturable virus in tears of a case-ascertained household cohort., Design: Prospective, longitudinal case-ascertained household cohort identified through convenience sampling., Methods: This analysis was restricted to individuals who were non-hospitalized, symptomatic, and tested positive for SARS-CoV-2 by nasal RT-PCR. Tears and anterior nasal biospecimens were serially collected throughout the acute period. Tears specimens were collected by the study staff using Schirmer test strips, and nasal specimens were self-collected. For both, SARS-CoV-2 RNA was quantified using qRT-PCR, and culturable virus was detected using presence of cytopathic effect (CPE) in tissue culture; positive CPE was confirmed by a qRT-PCR step. A series of cross-sectional unadjusted analyses were performed investigating the relationship between different sociodemographic determinants and biological factors associated with tears RNA positivity., Results: Among the 83 SARS-CoV-2 infected participants, 10 (12%) had at least one RNA-positive tears specimen. Amongst these 10, 5 (50%) had concurrent presence of culturable virus, at a median of 7 days postsymptom onset (IQR: 4-7 days) (absolute range: 4-8 days)., Conclusions: In this longitudinal cohort, we found evidence of culturable virus in the tears of a small proportion of nonhospitalized SARS-CoV-2 infected individuals. Current public health infection precautions do not account for transmission via tears, so these findings may improve our understanding of potential sources of SARS-CoV-2 transmission and contribute to developing future guidelines., (Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
6. Utilization of multiplex polymerase chain reaction for simultaneous and rapid detection of viral infections from different ocular structures.
- Author
-
Letafati A, Jazayeri SM, Atwan H, Mahmoudi MK, Sarrafzadeh S, Ardekani OS, Norouzi M, and Ghaziasadi A
- Subjects
- Humans, Female, Male, Middle Aged, Adult, Herpesvirus 1, Human genetics, Herpesvirus 1, Human isolation & purification, Aged, Eye Infections, Viral virology, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology, Herpesvirus 2, Human genetics, Herpesvirus 2, Human isolation & purification, Adolescent, Young Adult, Herpesvirus 3, Human genetics, Herpesvirus 3, Human isolation & purification, Virus Diseases diagnosis, Virus Diseases virology, Virus Diseases epidemiology, Child, Keratitis virology, Keratitis diagnosis, Keratitis epidemiology, Tears virology, Multiplex Polymerase Chain Reaction methods, Aqueous Humor virology
- Abstract
The impact of viral keratitis (VK) on individuals and society is notable. Early diagnosis and treatment are crucial in managing viral keratitis effectively. Timely intervention with antiviral medications and supportive care can help mitigate the severity of the infection and improve visual outcomes. We examined the prevalence of varicella-zoster virus (VZV), herpes simplex virus type 1 (HSV-1), adenovirus (AdV) and herpes simplex virus type 2 (HSV-2) in patients suspected for ocular infections. Patients included in the study exhibited various clinical manifestations indicative of ocular pathology, such as infectious keratitis, corneal scar, endogenous endophthalmitis, panuveitis, endothelitis, stromal edema, and other relevant conditions. Four different types of tear fluid, corneal samples epithelium, aqueous humor and vitreous humor were taken. After genome extraction, multiplex real-time PCR was used for diagnosis of viruses. 48 (29.6%) out of the total of 162 (100%) eye specimen were positive. The dominant prevalence was VZV (12.3%) and HSV-1 (11.7%) followed by AdV (4.9%) and HSV-2 (0.6%). There were 4 (8.3%) coinfections within the samples (HSV-1 and VZV). Aqueous humor samples demonstrated superior virus detection ability and our only HSV-2 positive sample was from aqueous humor. The utilization of multiplex real-time PCR assays in differential diagnosis of VK holds promise for expeditious diagnoses while also preventing unwarranted antibiotic prescriptions. Moreover, the aqueous humor appears to be a more sensitive site for detecting viral keratitis., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
7. Clinical and demographic profile of herpes zoster ophthalmicus: A hospital-based study of 1752 Indian patients.
- Author
-
Rathi A, Das AV, and Ramappa M
- Subjects
- Humans, Male, India epidemiology, Cross-Sectional Studies, Female, Middle Aged, Adult, Adolescent, Young Adult, Aged, Child, Retrospective Studies, Prevalence, Sex Distribution, Age Distribution, Child, Preschool, Aged, 80 and over, Visual Acuity, Incidence, Herpes Zoster Ophthalmicus epidemiology, Herpes Zoster Ophthalmicus diagnosis, Eye Infections, Viral epidemiology, Eye Infections, Viral diagnosis
- Abstract
Purpose: To describe the clinical and demographic profile of herpes zoster ophthalmicus (HZO) in patients presenting to a multitier ophthalmology hospital network in India., Methods: Cross-sectional hospital-based study included 3,004,470 new patients between August 2010 and October 2021. Patients with a clinical diagnosis of HZO in at least one eye were included. Data were collected using an electronic medical record system., Results: In total, 1,752 (0.058%) patients were diagnosed with HZO. Nearly two-thirds were male (63.76%) in the seventh decade of life (339;19.35% patients) with unilateral (98.34%) affliction. Higher prevalence was seen in patients from higher socioeconomic status (0.059%) and metropolitan geography (0.062%). Most common ocular signs included eyelid edema (44.19%), conjunctival congestion (65.69%), punctate keratopathy (23.36%), and anterior uveitis (21.22%). Of the 1,781 eyes, mild/no visual impairment was seen in 952 (53.45%) eyes, moderate in 258 (14.49%) eyes, and severe to blindness in 363 (20.39%) eyes. Oral antivirals were started within 72 h (Group A) in 361 (20.61%) patients and after 72 h in 1391 (79.39%) patients (Group B). Significantly lesser severity of ocular involvement was noted in Group A ( P < 0.00001). Surgical intervention was required in 211 (11.85%) eyes., Conclusion: HZO more commonly affects males in the seventh decade of life and is predominantly unilateral. It more commonly affects those from higher socioeconomic strata and metropolitan regions. Half of the eyes have mild or no visual impairment, while others have moderate to severe impairment. Institution of antivirals within 72 h is associated with less severe involvement. Surgical intervention is warranted in a tenth of the eyes., (Copyright © 2024 Copyright: © 2024 Indian Journal of Ophthalmology.)
- Published
- 2024
- Full Text
- View/download PDF
8. Demographic Factors Associated with Presenting for Eye Evaluation in the Partnership for Research on Vaccines and Infectious Diseases in Liberia III Natural History Study of Ebola Virus Disease.
- Author
-
Wallace ACD, Ross RD, Tawse K, Nyain R, Gargu C, Wentworth DE, Bishop RJ, and Eghrari AO
- Subjects
- Humans, Male, Female, Liberia epidemiology, Adult, Middle Aged, Young Adult, Adolescent, Child, Survivors, Eye Diseases epidemiology, Child, Preschool, Ebolavirus immunology, Risk Factors, Aged, Eye Infections, Viral epidemiology, Eye Infections, Viral virology, Hemorrhagic Fever, Ebola epidemiology, Hemorrhagic Fever, Ebola prevention & control
- Abstract
Purpose: Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD., Methods: The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates., Results: A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0%) followed up for baseline eye examination. Ebola survivors (635/661, 96.1%) and adult close contacts (727/767, 94.8%) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95% CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95% CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination., Conclusion: Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD., Competing Interests: There are no conflicts of interest., (Copyright: © 2024 Middle East African Journal of Ophthalmology.)
- Published
- 2024
- Full Text
- View/download PDF
9. Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestations.
- Author
-
Dmitriev AA, Odden J, Mora-Boellstorff D, Kinchington PR, Sheridan K, Viehman JA, Price D, Koscumb S, Marroquin O, Sahel JA, Kowalski RP, Jhanji V, and Errera MH
- Subjects
- Humans, Retrospective Studies, Male, Female, Risk Factors, Middle Aged, Aged, Adult, Incidence, Aged, 80 and over, Adolescent, Child, Young Adult, Keratitis epidemiology, Keratitis virology, Keratitis diagnosis, Child, Preschool, Uveitis, Anterior virology, Uveitis, Anterior diagnosis, Uveitis, Anterior epidemiology, Retinal Necrosis Syndrome, Acute diagnosis, Retinal Necrosis Syndrome, Acute virology, Retinal Necrosis Syndrome, Acute epidemiology, Polymerase Chain Reaction, DNA, Viral analysis, Herpes Zoster Ophthalmicus epidemiology, Herpes Zoster Ophthalmicus diagnosis, Herpes Zoster Ophthalmicus virology, Eye Infections, Viral epidemiology, Eye Infections, Viral virology, Eye Infections, Viral diagnosis, Herpesvirus 3, Human genetics, Herpesvirus 3, Human isolation & purification
- Abstract
Objective: To determine the frequency of herpes zoster ophthalmicus (HZO) and assess risk factors for developing uncommon ocular manifestations of laboratory-verified HZO., Design: Retrospective cohort study., Methods: The frequency of HZO out of all herpes zoster cases was calculated using International Classification of Diseases codes for patients seen at the University of Pittsburgh Medical Center from January 1, 2004 to October 31, 2021. We also collected demographic and clinical data of patients with HZO identified by polymerase chain reaction (PCR) detection of varicella zoster virus from January 1, 2011 to December 31, 2020., Results: The frequency of HZO from 2004 to 2021 in all ages was 4.2% and ranged from 2.7% to 6.7% annually, with a consistent increase of 2.9% from 2012 to 2021. After the live zoster vaccine became available in 2008, the frequency of HZO decreased by 5.1% from 2008 to 2012 in patients aged 60 and older. Among 50 cases of PCR-verified HZO, 62% represented clinically-common ocular manifestations, mostly comprised of 13 cases of keratitis and 10 cases of anterior uveitis. Fifteen cases of acute retinal necrosis (ARN) represented the majority of uncommon HZO manifestations (38%), which were significantly more likely to occur in immunosuppressed patients (unadjusted odds ratio 4.55, 95% confidence interval 1.29-13.83)., Conclusions: The overall frequency of HZO from 2004 to 2021 was 4.2% and has increased annually since 2012. Uncommon ocular manifestations of PCR-verified HZO, mostly comprised of ARN, were more likely to occur in immunosuppressed patients., (Copyright © 2023 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
10. Ophthalmic manifestations as the first presenting feature in dengue fever: a 10-year study.
- Author
-
Mishra A, Tripathi A, Bhirud A, Agrawal M, Gupta S, and Parihar J
- Subjects
- Humans, Vitreous Hemorrhage, Pandemics, Prospective Studies, Uveitis, Anterior, Abducens Nerve Diseases, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology, Keratitis, Dengue complications, Dengue diagnosis, Dengue epidemiology
- Abstract
Purpose: To report patients who first presented with various ocular manifestations and eventually ascertained to have underlying dengue. Methods: A prospective study was conducted at multiple tertiary eye-care centers in India from 2012 to 2022. Cases reporting initially with ocular features along with fever/past history of fever over the last two weeks or with clinical features of dengue were selected. After an ophthalmological examination, patients underwent complete serological and biochemical analysis and those with reduced platelet counts were evaluated for dengue. Results: Out of 564 cases, 15 patients were verified to be afflicted with dengue eventually. A rising trend of cases was seen every year and out of 15 cases, eight cases were reported during the Covid-19 pandemic (from 2020 to 2022), but were COVID-negative. 9 cases presented with acute redness followed by diminished vision. Seven cases presented a history of fever over the last few days and one had traveled from dengue endemic area. The various ocular presentations included subconjunctival hemorrhage, viral keratitis, anterior uveitis, sixth-nerve palsy, and vitreous hemorrhage. On serological examination, all 15 patients were detected to have low platelets. All cases responded well with supportive treatment and the ocular features subsided in all within a couple of weeks with good visual recovery. Conclusion: In a tropical nation, such as India, with endemic dengue zones and increasing figures of dengue lately, ophthalmologists must include dengue fever among the differential diagnoses in various ocular presentations like subconjunctival hemorrhage, viral keratitis, anterior uveitis, sixth nerve palsy, and vitreous hemorrhage. Abbreviations: DHF = dengue hemorrhagic fever, PCR = polymerase chain reaction, RT-PCR = real-time automated reverse transcriptase (RT-PCR), SD = standard deviation, MAC-ELIS = IgM antibodies capture enzyme-linked immunosorbent assay, RE = right eye, LE = left eye, CECT = Contrast-enhanced computed tomography., (#x00A9; The Authors.Romanian Society of Ophthalmology.)
- Published
- 2024
- Full Text
- View/download PDF
11. Clinical features of 26 cases of COVID-19-associated conjunctivitis.
- Author
-
Tajima A, Sassa Y, Ishio D, Yamashita S, Sadashima E, Arai R, Iwanaga K, Yoshida S, Sonoda KH, and Enaida H
- Subjects
- Humans, Aged, Retrospective Studies, COVID-19 complications, COVID-19 diagnosis, COVID-19 epidemiology, Hyperemia diagnosis, Conjunctivitis diagnosis, Conjunctivitis epidemiology, Conjunctivitis etiology, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology
- Abstract
Purpose: To explore the clinical features of COVID-19-associated conjunctivitis with the objective of preventing the spread of infection., Study Design: Retrospective cohort study., Methods: From March 2020 to March 2021, we retrospectively reviewed 26 (9.8%) consecutive COVID-19 patients with conjunctivitis among 282 COVID-19 cases admitted to our hospital. Clinical symptoms, onset date of conjunctivitis, time to patient recovery, and eye drop intervention were investigated. In addition, risk factors for developing conjunctivitis were statistically examined among 206 inpatients available for within 5 days of the onset. A multivariate analysis of conjunctivitis risk factors was performed., Results: Among the 282 COVID-19 patients, 4 (1.4%) had conjunctival hyperemia as the primary symptom. The median time of onset was 4 days after the COVID-19 onset. Hyperemia was observed in all cases, but other ocular symptoms were rare. The median duration of hyperemia was 3 days. A multiple logistic regression analysis revealed that a young age (p=0.005) and current smoking habit (p=0.027) were independent risk factors for conjunctivitis after COVID-19., Conclusions: COVID-19-associated conjunctivitis is rare in the elderly and strongly associated with a history of smoking. It often occurs in the early stages of infection, and while hyperemia is recognized as a clinical symptom, other ocular symptoms are rare or non-existent. Many cases recover within a short time., (© 2023. Japanese Ophthalmological Society.)
- Published
- 2024
- Full Text
- View/download PDF
12. COVID-19-related Conjunctivitis Review: Clinical Features and Management.
- Author
-
Binotti W and Hamrah P
- Subjects
- Humans, SARS-CoV-2, Conjunctiva, COVID-19 epidemiology, Conjunctivitis diagnosis, Conjunctivitis epidemiology, Conjunctivitis therapy, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology, Eye Infections, Viral therapy
- Abstract
Purpose: The ongoing coronavirus disease-2019 (COVID-19) pandemic has greatly impacted theworld. In this review article, we discuss the conjunctival and nasolacrimal mucosa as a potential route for the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) transmission, its ocular manifestations, and management., Methods: Literature review was conducted in the PubMed, Google Scholar and EMBASE databases using keywords such as "coronavirus", COVID-19", "SARS-CoV-2", "conjunctivitis", "ocular surface", "eye" and "ophthalmology"., Results: The ocular surface may serve as an entry point and reservoir for the virus. Frequency of hand-eye contact was an independent risk factor for COVID-19-related conjunctivitis. Therefore, appropriate protective eyewear or face shields are recommended, especially for health-care workers. Bilateral conjunctival sampling within 9 days of symptom onset provides a higher positive yield rate. Pooled analysis shows an incidence of 11.4% (95%CI = 6.4-17.2%) of ocular manifestations in patients with SARS-CoV-2 infection, including hospitalized and non-hospitalized patients., Conclusion: Conjunctivitis was the most common ocular manifestation, of which ocular redness or congestion, ocular pain, and follicular conjunctivitis were the most common presentation.COVID-19-related conjunctivitis has a self-limiting disease course, and treatment should be mainly supportive.
- Published
- 2023
- Full Text
- View/download PDF
13. Epidemiology and characteristics of common forms of anterior uveitis at initial presentation in a tertiary facility in Japan.
- Author
-
Okazawa R, Iwai S, Nagura K, Sora D, Sato T, Takayama K, Harimoto K, Kanda T, and Takeuchi M
- Subjects
- Humans, Middle Aged, Aged, Retrospective Studies, Japan epidemiology, Herpesvirus 3, Human genetics, Acute Disease, Aqueous Humor, DNA, Viral analysis, Herpes Zoster Ophthalmicus diagnosis, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology, Scleritis, Uveitis, Anterior diagnosis, Uveitis, Anterior epidemiology, Glaucoma, Glaucoma, Open-Angle
- Abstract
Purpose: To elucidate detailed epidemiological profile of common types of anterior uveitis (AU) in real-world clinical setting of a tertiary facility in Japan, and to evaluate the characteristic clinical findings at initial presentation., Study Design: Retrospective cohort study., Methods: Clinical charts of 275 patients (335 eyes) aged 52.5 ± 19.1 years were reviewed retrospectively. Herpetic AU was diagnosed by multiplex polymerase chain reaction tests using aqueous humor. Time of uveitis onset, gender, laterality, disease course since the initial onset of AU, visual acuity (VA) and intraocular pressure (IOP) at first visit, and definitive diagnosis were collected from clinical charts., Results: Acute AU (AAU) was the most common (21.8%) form of AU; followed by herpetic AU (20.7%) comprising Herpes Simplex Virus (HSV) (8.0%), Varicella Zoster Virus (VZV) (9.1%) and cytomegalo virus (CMV) (3.6%); scleritis (13.5%); diabetic iritis (7.6%), and Posner-Schlossman syndrome (5.5%). Unilateral AU constituted 78.2%, and VA less than 20/30 accounted for 31.2%. Of all the eyes, 16.1% had an IOP higher than 20 mmHg, out of which 37.0% had herpetic AU, followed by scleritis in 25.9%, and Posner-Schlossman syndrome (PSS) in 11.1%. AU patients over 60 years of age were 40.4%, in which 34.2% had herpetic AU, followed by scleritis in 14.4% and AAU in 13.5%. Herpetic AU patients were significantly older and had higher IOP compared with AAU patients., Conclusion: The most frequent AU was AAU, followed by herpetic AU. Herpetic AU patients were older and had higher intraocular pressure than AAU patients, although VA was equally impaired in both groups., (© 2022. Japanese Ophthalmological Society.)
- Published
- 2023
- Full Text
- View/download PDF
14. Sociodemographic predictors associated with the spectrum of non-opportunist neuroretinal disease of non-infectious etiology in patients with HIV/AIDS: A scoping review.
- Author
-
Gómez-Gualdrón SA, Sánchez-Uzcátegui MA, and Camacho-López PA
- Subjects
- Adolescent, Antiretroviral Therapy, Highly Active adverse effects, CD4 Lymphocyte Count, Child, Female, Humans, Male, Acquired Immunodeficiency Syndrome complications, Acquired Immunodeficiency Syndrome drug therapy, Eye Infections, Viral epidemiology, Retinal Diseases drug therapy, Retinal Diseases epidemiology, Retinal Diseases etiology
- Abstract
Background: Non-infectious retinal disease, even in the HAART era, continues to be one of the most common diagnoses in patients with HIV, with prevalences of up to 27% of cases. This study aims to characterize the association between demographic variables and their role. As a risk factor for the development of non-opportunistic non-infectious retinal disease in patients with HIV/AIDS., Methods: An integrative review of the literature was carried out according to Arksey O'Malley's approach, based on the PICO methodology and following the PRISMA recommendations; An exhaustive search was carried out in databases of articles that were filtered using established criteria, with their extraction and analysis carried out qualitatively., Results: Ocular manifestations from any cause develop from 35 years of age in patients with HIV/AIDS, with the highest risk for age-related macular degeneration over the fourth decade of life and for the development of neuroretinal disorder on the fifth decade of life; some studies report a slight tendency to diagnose macular degeneration in women and those who acquired AIDS through sexual contact; data contrasted with increased risk for diagnosing neuroretinal disorder in homosexual men who also use intravenous drugs, possibly due to oversampling in studies; non-Hispanic whites and African Americans were the races most commonly affected by neuroretinal disease; the means between the 11.3-14.5 years elapsed since the HIV diagnosis were more frequently associated with cognitive impairment and both in those with high or low CD4 counts, and in patients with high or low viral loads, neuroretinal disease without Statistically significant differences. Adherence and early initiation of HAART had a modest impact on the development of neuroretinal disease., Discussion: Even in the HAART era, non-infectious neuroretinal disease and cytomegalovirus retinitis remain the most frequent ocular diagnoses, however, different studies argue an increase in age-related non-infectious retinal diseases in patients with HIV, theories that are may explain by the increase in life expectancy, the metabolic effects of HAART itself or the generalized pro-inflammatory state in this group of patients, it is essential to recognize this new diagnostic challenge in order to direct preventive efforts through the use of cost-effective sociodemographic risk predictors towards that technological tools for diagnosis and treatment can be targeted., Conclusions: HIV/AIDS patients who present at the ophthalmological consultation with the suggested sociodemographic predictors have a high risk of visual impairment due to non-infectious retinopathy, therefore prevention, diagnosis and treatment efforts directed at these diseases should be increased., (Copyright © 2021 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
15. Complications of Adenoviral Keratoconjunctivitis in Ophthalmologists and Orthoptists: Epidemiology and Risk Factor, A Retrospective Questionnaire Analysis.
- Author
-
Metzger M, Navel V, Bouvet M, Pereira B, Hébraud J, Coutu A, Chiambaretta F, and Dutheil F
- Subjects
- Adenovirus Infections, Human epidemiology, Adult, Aged, Cross-Sectional Studies, Eye Infections, Viral epidemiology, Female, Follow-Up Studies, France epidemiology, Humans, Keratoconjunctivitis epidemiology, Male, Middle Aged, Morbidity trends, Retrospective Studies, Risk Factors, Surveys and Questionnaires, Time Factors, Vision, Low epidemiology, Visual Acuity, Young Adult, Adenovirus Infections, Human complications, Eye Infections, Viral complications, Keratoconjunctivitis complications, Ophthalmologists statistics & numerical data, Orthoptics statistics & numerical data, Risk Assessment methods, Vision, Low etiology
- Abstract
Purpose: The purpose of this study was to assess the medical history of adenoviral keratoconjunctivitis (AK) and subepithelial infiltrates (SEIs) among French ophthalmologists and orthoptists and the frequency of unreported occupational diseases. We also described short-term and long-term consequences of AK and evaluated associated factors., Methods: The REDCap questionnaire was diffused online several times over 7 consecutive months, from October 2019 to May 2020, through mailing lists (French Society of Ophthalmology, residents, and hospital departments), social networks, and by word of mouth., Results: Seven hundred ten participants were included with a response rate of 6.2% for ophthalmologists, 3.8% for orthoptists, and 28.3% for ophthalmology residents. The medical history of AK was found in 24.1% (95% confidence interval 21%-27.2%) of respondents and SEI in 43.9% (36.5%-51.3%) of the AK population. In total, 87.1% (82.1%-92.1%) of AK occupational diseases were not declared. In total, 57.7% of respondents took 9.4 ± 6.2 days of sick leave, mostly unofficial, and 95.7% stopped surgeries for 13.0 ± 6.6 days. Among the AK population, 39.8% had current sequelae, with 17.5% having persistent SEIs, 19.9% using current therapy, and 16.4% experiencing continuing discomfort. SEIs were associated with wearing contact lenses (odds ratio 3.31, 95% confidence interval 1.19-9.21) and smoking (4.07, 1.30-12.8). Corticosteroid therapy was associated with a greater number of sequelae (3.84, 1.51-9.75)., Conclusions: AK and SEI affect a large proportion of ophthalmologists and orthoptists, possibly for years, with high morbidity leading to occupational discomfort. Few practitioners asked for either to be recognized as an occupational disease. Associated factors would require a dedicated study., Competing Interests: The authors have no funding or conflicts of interest to disclose., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
16. Epidemiology of Viral Induced Anterior Uveitis.
- Author
-
Radosavljevic A, Agarwal M, Chee SP, and Zierhut M
- Subjects
- Humans, Chikungunya Fever epidemiology, Dengue, Eye Infections, Viral epidemiology, Hemorrhagic Fever, Ebola, Rubella epidemiology, Uveitis, Uveitis, Anterior epidemiology, Zika Virus, Zika Virus Infection
- Abstract
Purpose: Viral agents are the most common cause of infectious anterior uveitis worldwide. The purpose of this review is to analyze the frequency, gender and racial differences of viral anterior uveitis (VAU) in various populations., Methods: Systematized literature review of epidemiological reports of VAU cited in PubMed, EMBASE and the Cochrane Library database published until June 30th, 2020., Results: A total of 12 clinical studies on epidemiology of definite VAU and 36 clinical studies of presumed VAU were identified. Members of Herpesviridae family represent the most common causes of VAU. Other less frequently reported causes, such as rubella and endemic viruses (HTLV-1, Chikungunya, Dengue, Ebola, Zika virus) were also analyzed., Conclusion: HSV, VZV are prevalent worldwide. CMV is more frequent in Asia, and rubella in the West. However, due to globalization and air travel, HTLV-1, Chikungunya, Dengue and Ebola may become important causes of VAU across the world.
- Published
- 2022
- Full Text
- View/download PDF
17. LOW VULNERABILITY OF THE POSTERIOR EYE SEGMENT TO SARS-COV-2 INFECTION: Chorioretinal SARS-CoV-2 Vulnerability.
- Author
-
Künzel SE, Bürgel T, Künzel SH, Pohlmann D, Zeitz O, Joussen A, and Dubrac A
- Subjects
- COVID-19 virology, Eye Infections, Viral epidemiology, Eye Infections, Viral pathology, Humans, Posterior Eye Segment pathology, RNA, Viral genetics, Retinal Ganglion Cells pathology, Retinal Ganglion Cells virology, Serine Endopeptidases biosynthesis, COVID-19 epidemiology, Eye Infections, Viral virology, Gene Expression Regulation, Viral, Posterior Eye Segment virology, SARS-CoV-2, Serine Endopeptidases genetics, Virus Internalization
- Abstract
Purpose: Retinal manifestations have been described in COVID-19 patients, but it is unknown whether SARS-CoV-2, the causal agent in COVID-19, can directly infect posterior ocular tissues. Here, we investigate SARS-CoV-2 host factor gene expression levels and their distribution across retinal and choroidal cell types., Methods: Query of single-cell RNA sequencing data from human retina and choroid., Results: We find no relevant expression of two key genes involved in SARS-CoV-2 entry, ACE2 and TMPRSS2, in retinal cell types. By contrast, scarce expression levels could be detected in choroidal vascular cells., Conclusion: Given the current understanding of viral host cell entry, these findings suggest a low vulnerability of the posterior eye segment to SARS-CoV-2 with a potential weak spot in the vasculature, which could play a putative causative role in ocular lesions in COVID-19 patients. This may qualify the vasculature of the human posterior eye segment as an in vivo biomarker for life-threatening vascular occlusions in COVID-19 patients.
- Published
- 2022
- Full Text
- View/download PDF
18. Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from Brazil.
- Author
-
Gasparini MS, Dos Santos LM, Hamade AM, Gross LG, Favarato AP, de Vasconcellos JP, de Melo MB, Parise PL, Simeoni CL, Silva NB, da Silva Mori MA, Vieira AS, Dos Santos Farias A, Granja F, Schreiber AZ, Moretti ML, Proença-Modena JL, and Alves M
- Subjects
- Adult, Aged, Brazil, COVID-19 complications, COVID-19 pathology, COVID-19 Nucleic Acid Testing statistics & numerical data, Eye Infections, Viral epidemiology, Eye Infections, Viral pathology, Female, Humans, Male, Middle Aged, SARS-CoV-2 genetics, Tears virology, Viral Load, COVID-19 virology, Eye virology, Eye Infections, Viral virology, SARS-CoV-2 pathogenicity
- Abstract
In this cross-sectional study, we investigate the presence of Severe Acute Respiratory Syndrome Coronavirus 2 Ribonucleic Acid (SARS-CoV-2 RNA) in the tears of hospitalized COVID-19 patients. After laboratory confirmation of SARS-CoV-2 infection by reverse transcription polymerase chain reaction (RT-PCR) analysis, tear samples from both eyes of each patient were collected using conjunctival swab for RT-PCR. Detailed demographic profile, systemic and ocular symptoms, comorbidities, clinical, ancillary, and ocular manifestations were evaluated. Of the 83 patients enrolled in the study, 7 (8.43%) had SARS-CoV-2 RNA detected in the tear samples. Neutrophils' count, C-reactive protein, and D-dimer were higher in patients with SARS-CoV-2 detected in tears than in patients without virus in ocular surface samples. One patient with SARS-CoV-2 in tears showed mild ocular eyelid edema, hyperemia, and chemosis. No relevant ocular manifestations were detected in the other patients. Although the levels of viral RNA on ocular surface samples were low for most patients (5/7), with positivity only for gene N and CT higher than 30, two patients were positive for all viral targets tested ( N , E , and RpRd ), with viral load near 1 × 10
5 ePFU/mL, indicating that the ocular transmission of SARS-CoV-2 is a possibility that needs to be considered, especially in the hospital environment. Further studies need to be conducted to demonstrate whether infective viral particles could be isolated from tears.- Published
- 2021
- Full Text
- View/download PDF
19. Posterior Segment Ophthalmic Manifestations in Ebola Survivors, Sierra Leone.
- Author
-
Berry DE, Bavinger JC, Fernandes A, Mattia JG, Mustapha J, Harrison-Williams L, Teshome M, Vandy MJ, Shantha JG, and Yeh S
- Subjects
- Adolescent, Adult, Cataract diagnosis, Cataract virology, Disease Outbreaks, Ebolavirus isolation & purification, Epiretinal Membrane diagnosis, Epiretinal Membrane epidemiology, Epiretinal Membrane virology, Eye Diseases diagnosis, Eye Diseases epidemiology, Eye Diseases virology, Eye Infections, Viral epidemiology, Eye Infections, Viral virology, Female, Hemorrhagic Fever, Ebola epidemiology, Hemorrhagic Fever, Ebola virology, Humans, Male, Middle Aged, Posterior Eye Segment virology, Retinal Detachment diagnosis, Retinal Detachment epidemiology, Retinal Detachment virology, Sierra Leone epidemiology, Survivors, Uveitis, Posterior epidemiology, Uveitis, Posterior virology, Vitreous Body pathology, Young Adult, Eye Infections, Viral diagnosis, Hemorrhagic Fever, Ebola diagnosis, Posterior Eye Segment pathology, Uveitis, Posterior diagnosis
- Published
- 2021
- Full Text
- View/download PDF
20. SARS-CoV-2 on the ocular surface: is it truly a novel transmission route?
- Author
-
Chen X, Yu H, Mei T, Chen B, Chen L, Li S, Zhang X, and Sun X
- Subjects
- COVID-19 epidemiology, Eye Infections, Viral virology, Humans, Pandemics, COVID-19 transmission, Disease Transmission, Infectious statistics & numerical data, Eye Infections, Viral epidemiology, SARS-CoV-2
- Abstract
Since December 2019, the novel COVID-19 outbreak has spread rapidly around the globe and infected millions of people. Although the major transmission route of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered to be airborne droplets and close contact, the ocular transmission route has been reported with great concern. The current work summarises the characteristics of SARS-CoV-2, the ocular distribution of the major SARS-CoV-2 binding protein, and the experimental and clinical evidence of the ocular transmission route. Although it seems that the likelihood of the ocular surface being an infection gateway is low, SARS-CoV-2 infection or transmission via the ocular surface may cause conjunctivitis and other ocular discomfort. Therefore, good eye protection is an essential safeguard procedure, especially for medical staff., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
21. Limbal Stem Cell Deficiency Associated With Herpes Keratitis.
- Author
-
Carreno-Galeano JT, Dohlman TH, Yin J, and Dana R
- Subjects
- Corneal Diseases diagnosis, Corneal Diseases epidemiology, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology, Female, Follow-Up Studies, Humans, Keratitis, Herpetic diagnosis, Keratitis, Herpetic epidemiology, Male, Massachusetts epidemiology, Middle Aged, Morbidity trends, Retrospective Studies, Risk Factors, Time Factors, Corneal Diseases etiology, Eye Infections, Viral complications, Keratitis, Herpetic complications, Limbus Corneae pathology, Visual Acuity
- Abstract
Purpose: To describe the demographic features and clinical characteristics of patients with herpes keratitis (HK) and limbal stem cell deficiency (LSCD) and identify possible factors associated with development of LSCD after HK., Methods: In this retrospective case-series study, records of patients with a clinical diagnosis of HK seen at Massachusetts Eye and Ear over a 5-year period were reviewed for evidence of LSCD. Patient demographics, medical history, treatment, and best-corrected visual acuities (BCVAs) were recorded., Results: We identified 626 patients with HK. Fifty-seven had been diagnosed with LSCD (9.3%). Thirteen percent of patients with herpes zoster keratitis (N= 25) and 7% of patients with herpes simplex keratitis (N= 32) had LSCD (P = 0.01). Keratitis caused by herpes zoster virus [odds ratios (OR), 1.77; 95% confidence interval (CI), 0.97-3.19; P = 0.01], stromal involvement (OR, 2.28; 95% CI, 1.27-4.18; P = 0.02), and the use of topical antihypertensives (OR, 2.28; 95% CI, 1.27-4.18; P = 0.02) were found to be associated with a higher likelihood of developing LSCD. The final logarithm of the minimum angle of resolution (LogMAR) BCVA was significantly lower in patients with LSCD compared with those without LSCD with a mean BCVA of 1.34 ± 1.52 LogMar (∼20/200) as compared to 0.18 ± 0.54 LogMar (∼20/30 ± 20/60) in those patients without LSCD (P = 0.005)., Conclusions: Our data suggest that HK may be a risk factor for development of LSCD. Patients with HK should be monitored for the development of LSCD to reduce the risk of chronic ocular surface morbidity., Competing Interests: The authors have no funding or conflicts of interest to disclose., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
22. Herpes Zoster: A Brief Definitive Review.
- Author
-
Cohen EJ and Jeng BH
- Subjects
- Eye Infections, Viral epidemiology, Eye Infections, Viral virology, Global Health, Herpes Zoster Ophthalmicus epidemiology, Herpes Zoster Ophthalmicus virology, Humans, Incidence, Antiviral Agents therapeutic use, Eye Infections, Viral therapy, Herpes Zoster genetics, Herpes Zoster Ophthalmicus therapy, Herpes Zoster Vaccine therapeutic use, RNA, Viral analysis, Vaccination methods
- Abstract
Abstract: This brief definitive review of herpes zoster (HZ) will cover the current state of knowledge and questions that remain to be answered regarding HZ in general and HZ ophthalmicus in particular. A question-and-answer format will be used to address various important topics related to this common and serious disease. Questions to be addressed relate to common misconceptions, contagiousness of infection, unknowns regarding pathogenesis, rising incidence, risk factors and complications, relationship with temporal arteritis, vaccination, and current and future antiviral treatment. In addition, the importance of the Zoster Eye Disease Study to determine the efficacy of suppressive valacyclovir treatment in preventing complications of HZ ophthalmicus and the need to support enrollment will be discussed., Competing Interests: The authors have no conflicts of interest to disclose., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. New evidence of SARS-CoV-2 transmission through the ocular surface.
- Author
-
Qing H, Yang Z, Shi M, and Zhang Z
- Subjects
- COVID-19 epidemiology, Humans, Pandemics, COVID-19 transmission, Disease Transmission, Infectious statistics & numerical data, Eye Infections, Viral epidemiology, SARS-CoV-2
- Published
- 2021
- Full Text
- View/download PDF
24. Receptors modulation on the ocular surface: A novel insight into the ocular infection and disease transmission of SARS-COV-2.
- Author
-
Kaushik J, Singh A, Kochhar D, Murari T, Shetty R, and Parihar JKS
- Subjects
- Angiotensin-Converting Enzyme 2 metabolism, COVID-19 epidemiology, COVID-19 prevention & control, COVID-19 virology, Conjunctiva metabolism, Conjunctiva virology, Cornea metabolism, Cornea virology, Eye Infections, Viral epidemiology, Eye Infections, Viral prevention & control, Eye Infections, Viral virology, Humans, Serine Endopeptidases metabolism, COVID-19 transmission, Eye Infections, Viral transmission, SARS-CoV-2 isolation & purification
- Published
- 2021
- Full Text
- View/download PDF
25. The eye: "An organ that must not be forgotten in coronavirus disease 2019 (COVID-2019) pandemic".
- Author
-
Durán C SC and Mayorga G DC
- Subjects
- Animals, Conjunctivitis, Viral diagnosis, Disease Models, Animal, Eye Infections, Viral diagnosis, Humans, COVID-19 epidemiology, Conjunctivitis, Viral epidemiology, Eye, Eye Infections, Viral epidemiology, SARS-CoV-2 isolation & purification, Tears virology
- Abstract
The coronavirus family is a group of zoonotic viruses with some recognized reservoirs particularly some bats. A novel coronavirus emerged in the province of Wuhan (China) in December of 2019.The number of infected patient with serious respiratory infection quickly spread around the world to become a global pandemic. The clinical presentation and viral pathogenesis of the coronavirus disease named COVID-19 indicated that the virus is transmitted from person to person through infected droplets entering the respiratory mucosa. Close contact with infected individuals particularly in crowded environments has characterized the rapid spread of the infection. Clinical manifestations of the viral infection have mentioned the presence of some ocular findings such as conjunctival congestion, conjunctivitis and even corneal injury associated with the classical COVID-19 infection. Some animal models of different coronaviruses eye infections have described the viral pathogenesis through tear and conjunctival sampling. On the other hand, we are recommended protective measure to prevent contagion and limit the spread of the virus in health care professionals and contact lenses wearers., (Copyright © 2020 Spanish General Council of Optometry. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
26. Ocular manifestations of emerging viral diseases.
- Author
-
Venkatesh A, Patel R, Goyal S, Rajaratnam T, Sharma A, and Hossain P
- Subjects
- Animals, Arthropod Vectors, Communicable Diseases, Emerging epidemiology, Disease Outbreaks, Eye Infections, Viral epidemiology, Humans, RNA Viruses pathogenicity, Viral Zoonoses, Virus Diseases epidemiology, Communicable Diseases, Emerging diagnosis, Eye Infections, Viral diagnosis, Virus Diseases diagnosis
- Abstract
Emerging infectious diseases (EIDs) are an increasing threat to public health on a global scale. In recent times, the most prominent outbreaks have constituted RNA viruses, spreading via droplets (COVID-19 and Influenza A H1N1), directly between humans (Ebola and Marburg), via arthropod vectors (Dengue, Zika, West Nile, Chikungunya, Crimean Congo) and zoonotically (Lassa fever, Nipah, Rift Valley fever, Hantaviruses). However, specific approved antiviral therapies and vaccine availability are scarce, and public health measures remain critical. Patients can present with a spectrum of ocular manifestations. Emerging infectious diseases should therefore be considered in the differential diagnosis of ocular inflammatory conditions in patients inhabiting or returning from endemic territories, and more general vigilance is advisable in the context of a global pandemic. Eye specialists are in a position to facilitate swift diagnosis, improve clinical outcomes, and contribute to wider public health efforts during outbreaks. This article reviews those emerging viral diseases associated with reports of ocular manifestations and summarizes details pertinent to practicing eye specialists.
- Published
- 2021
- Full Text
- View/download PDF
27. Ophthalmic manifestations in the COVID-19 clinical spectrum.
- Author
-
Kumar KK, Sampritha UC, Prakash AA, Adappa K, Chandraprabha S, Neeraja TG, Guru Prasad NS, Basumatary J, Gangasagara SB, Sujatha Rathod BL, and Jayanthi CR
- Subjects
- Adult, Aged, COVID-19 epidemiology, Conjunctivitis, Viral diagnosis, Conjunctivitis, Viral epidemiology, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology, Female, Humans, India epidemiology, Male, Middle Aged, Prospective Studies, COVID-19 complications, Conjunctivitis, Viral etiology, Eye Infections, Viral etiology, Pandemics, SARS-CoV-2
- Abstract
Purpose: The aim of this study was to determine the frequency and various types of ophthalmic manifestation of patients with COVID-19., Methods: This is a prospective observational study conducted on patients with SARS-Co-V-2 infection, at a dedicated tertiary COVID-19 hospital in South India from April 1 to July 31, 2020. At the time of their admission to the COVID hospital, demographic data such as name, age, sex was recorded. A thorough history regarding the onset, duration, progression, nature of symptoms and its associated factors, medication history, treatment history were elicited and documented. Ocular examination was performed under torchlight by an ophthalmologist posted for COVID duty. Further investigations including imaging were sought for, depending on clinical indications. Serial follow-up examinations of all patients were carried out every 72 hours or when patients complained of any ocular symptoms whichever earlier, until discharge. All relevant data were compiled and statistically analyzed., Results: A total of 2742 patients were examined. Of them, 1461 (53.28%) were males and 1281 (46.72%) were females. The mean age (±SD) was 39.46 ± 17.63 years. None of the patients in our study had any ocular symptoms or signs as the presenting complaint at the time of their admission. On subsequent follow-up, only 20 (0.72%) developed ocular manifestations, of which 19 (95%) had features suggestive of Bilateral viral conjunctivitis. However, 1 (5%) patient had orbital cellulitis secondary to pansinusitis., Conclusion: Ophthalmic manifestations in the clinical spectrum of COVID-19 infection are uncommon and unlikely to be the presenting clinical impression. However, it has broadened our view to a wider spectrum of COVID-19 presentations enhancing our clinical acumen for staunch detection of COVID-19 suspects in our daily practice, augmenting early diagnosis and management and also break the chain of transmission for the greater good of humanity., Competing Interests: None
- Published
- 2021
- Full Text
- View/download PDF
28. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19.
- Author
-
Sen M, Honavar SG, Sharma N, and Sachdev MS
- Subjects
- COVID-19 complications, Eye Infections, Viral epidemiology, Humans, COVID-19 epidemiology, Eye Infections, Viral etiology, Pandemics, SARS-CoV-2
- Abstract
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had health implications of unprecedented magnitude. The infection can range from asymptomatic, mild to life threatening respiratory distress. It can affect almost every organ of the body. Ophthalmologists world over are reporting various manifestations of the infection in the eye. This review was undertaken to help ophthalmologists recognize the possible manifestations and the stage of the viral disease when they commonly appear. Literature search was performed for the publications on ophthalmic manifestations of coronavirus disease-19 (COVID-19) between January 1, 2020 and January 31, 2021. 46 case reports, 8 case series, 11 cross sectional/cohort observational studies, 5 prospective interventional studies, 3 animal models/autopsy studies and 6 reviews/meta-analysis were included. Conjunctivitis is the most common manifestation and can develop at any stage of the disease. Direct effect due to virus, immune mediated tissue damage, activation of the coagulation cascade and prothrombotic state induced by the viral infection, the associated comorbidities and drugs used in the management are responsible for the findings in the eye. The viral ribonucleic acid (RNA) has been isolated from ocular tissues but the role of eye as a route for infection is yet to be substantiated. Ophthalmic manifestations may be the presenting feature of COVID-19 infection or they may develop several weeks after recovery. Ophthalmologists should be aware of the possible associations of ocular diseases with SARS-CoV-2 in order to ask relevant history, look for specific signs, advise appropriate tests and thereby mitigate the spread of infection as well as diagnose and initiate early treatment for life and vision threatening complications., Competing Interests: None
- Published
- 2021
- Full Text
- View/download PDF
29. Identification of Potential Biomarkers in Peripheral Blood Supernatants of South African Patients with Syphilitic and Herpetic Uveitis.
- Author
-
Andreae CD, Smit DP, Makhoba NS, Kidd M, Walzl G, and Chegou NN
- Subjects
- Adult, Aged, Biomarkers blood, Eye Infections, Bacterial diagnosis, Eye Infections, Bacterial epidemiology, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology, Female, Humans, Incidence, Male, Middle Aged, South Africa epidemiology, Syphilis diagnosis, Uveitis diagnosis, Uveitis epidemiology, Young Adult, Eye Infections, Bacterial blood, Eye Infections, Viral blood, Eye Proteins blood, Syphilis blood, Uveitis blood
- Abstract
Purpose : To identify potential diagnostic biomarkers for herpetic and syphilitic uveitis. Methods : Blood samples were collected from 92 uveitis patients. Concentrations of 47 biomarkers were evaluated in unstimulated Quantiferon supernatants using the Luminex platform. Results : Results showed 11 patients (12%) had herpetic uveitis, 11 (12%) syphilis, 40 (43.5%) other infectious causes, 16 (17.4%) established noninfectious causes and 14 (15.2%) were idiopathic. Biomarker analysis revealed three proteins (Apo-A1, Apo-CIII, CRP) that differed between syphilis and other causes. A three-marker biosignature (CCL4/MIP-1β, Apo-CIII and CRP) separated syphilis from other groups with AUC = 0.83 (95% CI: 0.68-0.98). Apo-CIII and CRP differed between herpetic cases and other groups ( p < .05). A three-analyte biosignature (Apo-A1, SAP and CRP) separated the herpetic group from other groups with AUC = 0.79 (95% CI: 0.65-0.93). Conclusion : We have identified candidate biomarkers with potential to differentiate between herpetic, syphilitic and other causes of uveitis. These results warrant further investigation in larger future studies.
- Published
- 2021
- Full Text
- View/download PDF
30. Ocular involvement in coronavirus disease 2019 (COVID-19): a clinical and molecular analysis.
- Author
-
Shemer A, Einan-Lifshitz A, Itah A, Dubinsky-Pertzov B, Pras E, and Hecht I
- Subjects
- Aged, Eye Infections, Viral diagnosis, Eye Infections, Viral virology, Female, Humans, Incidence, Israel epidemiology, Male, Middle Aged, Retrospective Studies, COVID-19 epidemiology, Eye Infections, Viral epidemiology, Pandemics, RNA, Viral analysis, SARS-CoV-2 genetics
- Abstract
Purpose: Coronavirus disease 2019 (COVID-19) caused a global pandemic with millions infected worldwide. Little is known on the ocular involvement associated with the disease. The aim of this study was to assess the clinical and molecular ocular involvement among patients with confirmed COVID-19 admitted to a tertiary care facility., Methods: Consecutive patients admitted to the COVID-19 Ward of the Shamir Medical Center in Israel during March and April, 2020 were included. The control group included patients negative for COVID-19 admitted during a similar period to a different ward. Patients were examined by trained Ophthalmologists. SARS-CoV-2 conjunctival swab samples were obtained., Results: Included were 48 patients, 16 with confirmed COVID-19 and 32 controls. Median patient age was 68.5 (interquartile range: 31.5, mean: 63 ± 21) years and 48% were male. Active conjunctival injection was present in three patients (19%) with COVID-19, compared to none in the controls (p = 0.034). Patients with COVID-19 were more likely to complain of foreign body sensation (31.3% vs 3.1%, p = 0.005) and redness of the eye (25% vs 0%, p = 0.003). Conjunctival injection was associated with loss of smell and taste (75% vs 7.7%, p = 0.018). Viral conjunctival swab tests all showed negative results for all three viral genes tested (E, N, and RdRp)., Conclusions: Among patients admitted to a tertiary referral center with confirmed COVID-19, active conjunctival injection was noted in one out of five cases, and was associated with loss of smell and taste. Conjunctival swabs for viral RNA were negative in patients with and without ocular involvement.
- Published
- 2021
- Full Text
- View/download PDF
31. Zika Virus and Anterior Uveitis-4 Years After the Pandemic.
- Author
-
Agrawal R, Seah I, and Leo YS
- Subjects
- Adult, Humans, Pandemics, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology, Uveitis, Anterior diagnosis, Uveitis, Anterior epidemiology, Zika Virus, Zika Virus Infection diagnosis, Zika Virus Infection epidemiology
- Published
- 2021
- Full Text
- View/download PDF
32. SARS-CoV-2 and COVID-19 for the ophthalmologist.
- Author
-
Brandão-de-Resende C, Diniz-Filho A, de Almeida Brito F, and Vasconcelos-Santos DV
- Subjects
- COVID-19 diagnosis, COVID-19 therapy, COVID-19 virology, Education, Medical, Continuing, Eye Infections, Viral diagnosis, Eye Infections, Viral epidemiology, Eye Infections, Viral therapy, Eye Infections, Viral virology, Humans, Pneumonia, Viral diagnosis, Pneumonia, Viral epidemiology, Pneumonia, Viral therapy, Pneumonia, Viral virology, Respiratory Tract Infections diagnosis, Respiratory Tract Infections epidemiology, Respiratory Tract Infections therapy, Respiratory Tract Infections virology, COVID-19 epidemiology, Ophthalmologists, SARS-CoV-2
- Abstract
The COVID-19 pandemic has had an unprecedented impact on ophthalmology. This review compiles general aspects of the novel coronavirus and COVID-19, further dissects the most recent data on the role of the eye regarding disease transmission and manifestations, and summarizes preventive measures in the particular context of eye care., (© 2020 Royal Australian and New Zealand College of Ophthalmologists.)
- Published
- 2021
- Full Text
- View/download PDF
33. Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye.
- Author
-
Al-Sharif E, Strianese D, AlMadhi NH, D'Aponte A, dell'Omo R, Di Benedetto R, and Costagliola C
- Subjects
- Animals, COVID-19 epidemiology, Eye Infections, Viral epidemiology, Global Health, Humans, Incidence, Tropism, COVID-19 transmission, Disease Transmission, Infectious statistics & numerical data, Eye Infections, Viral virology, Pandemics, SARS-CoV-2
- Abstract
Purpose: Several studies have reported conflicting results on ocular manifestations and transmission of coronavirus disease 2019 (COVID-19) whose causative virus, SARS-CoV-2, belongs to the coronavirus family, the seventh recognized as a human pathogen and the third causing a severe clinical syndrome. COVID-19 primarily affects the lungs, similar to the other human coronaviruses. Comparing the relation between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-Cov-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye may contribute to determining their actual eye-tissue tropism and risk of ocular transmission., Methods: Literature review was conducted via Pubmed.gov, Google Scholar and medRixv using the following keywords: COVID-19, SARS-CoV-2, SARS-CoV-1, MERS-CoV, CoV-229E, NL63, OC43, HKU1, conjunctivitis, tear swab, ocular expression, ocular symptoms and human angiotensin converting enzyme-2 expression. Studies with lack in methodology were excluded., Results: Sixteen observational studies were selected. The range for detection of viral RNA in tears was 0-8% for SARS-CoV-1 and 0-5.3% for SARS-CoV-2, while no reports were found for other coronaviruses. Ocular manifestations have been reported for NL63 and SARS-CoV-2. Ocular symptoms in the form of conjunctivitis/conjunctival congestion predominantly were detected in 65 (3.17%) out of 2048 reported patients with COVID-19 (range of 0.8-32%). Eye symptoms were not reported for the other coronaviruses., Conclusions: Data aggregation for coronaviruses shows a relatively low eye-tissue tropism. Conjunctival congestion is an uncommon manifestation of COVID-19 similar to all human coronaviruses' infections. In a low percentage of patients, the virus can be excreted in ocular fluids at different stages of the infection, regardless of positive SARS-Cov-2 throat swab. Albeit high viral loads in ocular tissue seem to have relatively low prevalence, the eye should be regarded as a potential source of infection dissemination for COVID-19.
- Published
- 2021
- Full Text
- View/download PDF
34. 2020: What Should Have Been Our Year.
- Author
-
Megalla M
- Subjects
- Eye Infections, Viral therapy, Female, Humans, Male, COVID-19 epidemiology, Disease Management, Eye Infections, Viral epidemiology, Ophthalmology, Pandemics
- Published
- 2020
- Full Text
- View/download PDF
35. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.
- Author
-
Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, Qin Y, Xiao K, Zhang H, and Sun X
- Subjects
- Adolescent, Adult, Aged, COVID-19 epidemiology, COVID-19 virology, COVID-19 Testing, China epidemiology, Conjunctivitis, Viral epidemiology, Conjunctivitis, Viral virology, Cross-Sectional Studies, Eye Infections, Viral epidemiology, Eye Infections, Viral virology, Female, Humans, Male, Middle Aged, RNA, Viral genetics, Reverse Transcriptase Polymerase Chain Reaction, SARS-CoV-2 genetics, Surveys and Questionnaires, Young Adult, COVID-19 diagnosis, Conjunctivitis, Viral diagnosis, Eye Infections, Viral diagnosis, Nasopharynx virology, SARS-CoV-2 isolation & purification
- Abstract
Purpose: To investigate the ocular manifestations and clinical characteristics of COVID-19 patients caused by SARS-CoV-2 in Wuhan, China., Methods: A total of 535 COVID-19 patients were recruited at Mobile Cabin Hospital and Tongji Hospital. Information on demographic characteristics, exposure history, ocular symptoms, eye drop medication, eye protections, chronic eye diseases, systemic concomitant symptoms, radiologic findings and SARS-CoV-2 detection in nasopharyngeal swabs by real-time PCR was collected from questionnaires and electronic medical records., Results: Of 535 patients, 27 patients (5.0%) presented with conjunctival congestion and 4 patients had conjunctival congestion as the initial symptom. The average duration of conjunctival congestion was 5.9 ± 4.5 days (mean [SD]). The other ocular symptoms, including increased conjunctival secretion, ocular pain, photophobia, dry eye and tearing, were also found in patients with conjunctival congestion. Notably, hand-eye contact was independently correlated with conjunctival congestion in COVID-19 patients. We also found that some COVID-19 patients had chronic eye diseases, including conjunctivitis (33, 6.2%), xerophthalmia (24, 4.5%) and keratitis (14, 2.6%). Similar to the published studies, the most common clinical symptoms were fever, cough and fatigue. A total of 343 patients (64.1%) had positive SARS-CoV-2 detection in nasopharyngeal swabs., Conclusions: Conjunctival congestion is one of the COVID-19-related ocular symptoms, which could occur as the initial symptoms. Frequent hand-eye contact may be the risk factor for conjunctival congestion in COVID-19 patients. Screening of patients with conjunctival congestion by ophthalmologists is advocated during the outbreak of COVID-19. It is essential to provide eye-care equipment and strengthen education on eye protection., (© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
36. Staring Death in the Eyes: Fighting on the COVID Frontline as an Ophthalmologist.
- Author
-
Nair AA
- Subjects
- Aged, Eye Infections, Viral therapy, Female, Humans, Male, Middle Aged, COVID-19 epidemiology, Disease Management, Disease Transmission, Infectious prevention & control, Eye Infections, Viral epidemiology, Ophthalmologists, Pandemics, SARS-CoV-2
- Published
- 2020
- Full Text
- View/download PDF
37. Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan.
- Author
-
Kamoi K, Okayama A, Izumo S, Hamaguchi I, Uchimaru K, Tojo A, Watanabe T, and Ohno-Matsui K
- Subjects
- Adult, Endemic Diseases, Eye Infections, Viral virology, Female, HTLV-I Antibodies analysis, HTLV-I Infections epidemiology, HTLV-I Infections virology, Human T-lymphotropic virus 1 genetics, Human T-lymphotropic virus 1 immunology, Humans, Incidence, Japan epidemiology, Male, Middle Aged, Retrospective Studies, Eye Infections, Viral epidemiology, Population Surveillance methods
- Abstract
Introduction: Japan is the most endemic of the developed nations in terms of human T-lymphotropic virus type 1 (HTLV-1) infection. Japan has been tackling HTLV-1 infection and has made remarkable progress. In ophthalmology, awareness of the association between HTLV-1 infection and uveitis has been increasing since the 1990s, when the relationship was first established. Here, we describe a nationwide survey and analysis of the current state of medical care for HTLV-1-associated uveitis (HAU) at ophthalmic facilities in Japan., Methods: A questionnaire survey covered all university hospitals in Japan that were members of the Japanese Ophthalmological Society and all regional core facilities that were members of the Japanese Ocular Inflammation Society. Survey data were collected, and nationwide data on the state of medical care for HAU were tallied and analysed., Results: Of the 115 facilities, 69 (60.0%) responded. HAU was most commonly diagnosed 'based on blood tests and characteristic ophthalmic findings'. Overall, 86.8% of facilities perform testing for HTLV-1 antibodies during medical care for diagnosing uveitis, with 58.3% routinely performing testing. Facilities with experience in providing medical care for HAU accounted for 67.6%. The survey also revealed that 85.5% of facilities had seen no decrease in the number of patients with HAU., Conclusions: In the two decades since the establishment of HAU as a pathological entity, the majority of facilities in Japan have started performing testing for HTLV-1 antibodies when considering differential diagnoses for uveitis. Our data suggest that providing information on HTLV-1 infection to ophthalmologists in Japan has been successfully implemented., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
38. 7:00 PM: A Time for Gratitude and Reflection.
- Author
-
Lidder AK
- Subjects
- Eye Infections, Viral prevention & control, Female, Humans, Male, Surveys and Questionnaires, COVID-19 epidemiology, Disease Transmission, Infectious prevention & control, Eye Infections, Viral epidemiology, Ophthalmology methods, Pandemics
- Published
- 2020
- Full Text
- View/download PDF
39. SARS-CoV-2 Targeting the Retina: Host-virus Interaction and Possible Mechanisms of Viral Tropism.
- Author
-
de Figueiredo CS, Raony Í, and Giestal-de-Araujo E
- Subjects
- COVID-19, Coronavirus Infections epidemiology, Eye Infections, Viral epidemiology, Humans, Pandemics, Pneumonia, Viral epidemiology, SARS-CoV-2, Betacoronavirus physiology, Coronavirus Infections virology, Eye Infections, Viral virology, Pneumonia, Viral virology, Retina virology, Viral Tropism
- Abstract
Background: Coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 10 (SARS-CoV-2). Recent studies demonstrated not only retinal impairments but also detected SARS-CoV-2 in the retina of patients with COVID-19. Purpose: This letter discusses the retinal tropism of SARS-CoV-2, describing possible routes for this coronavirus to reach the retina and cellular mechanisms involved in the retinal cell infection. Conclusions: Determining how SARS-CoV-2 can affect the retinal tissue is essential for the development of new therapeutic strategies and preventive measures, as well as for understanding the possible relationship between COVID-19 damage to the retina and to the brain.
- Published
- 2020
- Full Text
- View/download PDF
40. Acute Onset of Bilateral Follicular Conjunctivitis in two Patients with Confirmed SARS-CoV-2 Infections.
- Author
-
Lim LW, Tan GS, Yong V, Anderson DE, Lye DC, Young B, and Agrawal R
- Subjects
- Adult, COVID-19, Conjunctivitis, Viral epidemiology, Coronavirus Infections transmission, Eye Infections, Viral epidemiology, Humans, Incidence, Male, Pandemics, Pneumonia, Viral transmission, Real-Time Polymerase Chain Reaction, SARS-CoV-2, Singapore epidemiology, Betacoronavirus genetics, Conjunctivitis, Viral virology, Coronavirus Infections epidemiology, Eye Infections, Viral virology, Pneumonia, Viral epidemiology, RNA, Viral analysis
- Abstract
Purpose: To report bilateral follicular conjunctivitis in two confirmed Coronavirus (COVID-19) patients with the presence of Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) in conjunctival swab specimens., Participants and Methods: Two unrelated patients with confirmed SARS-CoV-2 infection and bilateral acute conjunctivitis were examined. Conjunctival swabs were assessed for the presence of SARS-CoV-2 by quantitative real-time polymerase chain reaction (RT-PCR) and viral culture., Results: Both patients developed eye redness 3 days after the onset of COVID-19 symptoms. Slit lamp examination showed bilateral acute follicular conjunctivitis, which was resolved within 6 days. RT-PCR demonstrated the presence of viral RNA in conjunctival specimens from both eyes, which was unrelated to viral RNA from throat swabs., Conclusion: SARS-CoV-2 may cause ocular manifestations such as viral conjunctivitis. Conjunctival sampling may be useful for infected patients with conjunctivitis and fever. Precautionary measures are recommended when examining infected patients throughout the clinical course of the infection.
- Published
- 2020
- Full Text
- View/download PDF
41. Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding.
- Author
-
Ocansey S, Abu EK, Abraham CH, Owusu-Ansah A, Boadi-Kusi SB, Ilechie AA, and Acheampong DO
- Subjects
- COVID-19, Comorbidity, Coronavirus Infections transmission, Coronavirus Infections virology, Eye Infections, Viral epidemiology, Humans, Pneumonia, Viral transmission, Pneumonia, Viral virology, SARS-CoV-2, Betacoronavirus, Conjunctiva virology, Coronavirus Infections epidemiology, Disease Transmission, Infectious, Eye Infections, Viral virology, Pandemics, Pneumonia, Viral epidemiology, Virus Shedding
- Abstract
The recently identified novel coronavirus (CoV), the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causes the coronavirus disease 2019 (COVID-19). While published data about other highly infectious human COVs [that is, the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)] provide helpful information about the infectivity of SARS-CoV-2, there is limited understanding surrounding knowledge of ocular manifestation of the virus. This paper reviews published data which reveal the presence of SARS-CoV-2 RNA in tears and conjunctival scrappings of some COVID-19 patients by real-time-polymerase chain reaction assay, although the detection rate is low compared to samples from respiratory sites. Nevertheless, the ocular complications from SARS-CoV-2 infection are uncommon. The evidence partly supports the eye as a portal of entry for SARS-CoV-2 to infect respiratory cells or viral shedding from respiratory cells via the nasolacrimal duct unto the ocular surface. The possibility of ocular secretions as source for SARS-CoV-2 to spread externally has substantial public health implications.
- Published
- 2020
- Full Text
- View/download PDF
42. Conjunctivitis in COVID-19 patients: frequency and clinical presentation.
- Author
-
Güemes-Villahoz N, Burgos-Blasco B, García-Feijoó J, Sáenz-Francés F, Arriola-Villalobos P, Martinez-de-la-Casa JM, Benítez-Del-Castillo JM, and Herrera de la Muela M
- Subjects
- Aged, Aged, 80 and over, COVID-19, Conjunctivitis, Viral diagnosis, Coronavirus Infections diagnosis, Cross-Sectional Studies, Eye Infections, Viral diagnosis, Female, Hospitalization, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral diagnosis, Prevalence, Risk Factors, SARS-CoV-2, Spain epidemiology, Betacoronavirus isolation & purification, Conjunctivitis, Viral epidemiology, Coronavirus Infections epidemiology, Eye Infections, Viral epidemiology, Pneumonia, Viral epidemiology
- Abstract
Purpose: The purpose of this study was to evaluate the frequency and clinical presentation of conjunctivitis in hospitalized patients with COVID-19., Methods: A cross-sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. A total of 301 subjects from the COVID admission unit with laboratory-confirmed SARS-CoV-2 infection were included. The presence and clinical characteristics of conjunctivitis were evaluated. Laboratory, radiological, and clinical results in patients with and without conjunctivitis stratified by sex were analyzed., Results: Of the 301 subjects included, 180 patients (59.8%) were male and the median age was 72 years (IQ 59-82). Overall, 35 patients (11.6%) were diagnosed with acute conjunctivitis. We found no relationship between the COVID-19 severity score and the presence of conjunctivitis (P = 0.17). However, conjunctivitis was more frequent in males with moderate clinical severity and in women classified as clinically mild. The natural history of the disease seems to be a rapid self-limited conjunctivitis that improves without treatment and does not affect visual acuity nor associate short-term complications., Conclusions: Approximately, 1 out of 10 hospitalized non-critical COVID-19 patients presents conjunctivitis during the disease. Compared with other viral conjunctivitis, we found distinctive clinical findings that could guide defining and differentiating conjunctivitis in COVID-19 patients., Trial Registration Number: 20/336_E_COVID.
- Published
- 2020
- Full Text
- View/download PDF
43. Adoption of Innovation in Herpes Simplex Virus Keratitis.
- Author
-
Chodosh J and Ung L
- Subjects
- Antiviral Agents therapeutic use, Corneal Diseases classification, Corneal Diseases epidemiology, Evidence-Based Medicine, Eye Infections, Viral classification, Eye Infections, Viral epidemiology, Glucocorticoids therapeutic use, Humans, Keratitis, Herpetic classification, Keratitis, Herpetic epidemiology, Corneal Diseases therapy, Eye Infections, Viral therapy, Keratitis, Herpetic therapy, Therapies, Investigational
- Abstract
Herpes simplex keratitis, caused primarily by human herpes simplex virus type 1 (HSV-1), remains the most common infectious cause of unilateral blindness and vision impairment in the industrialized world. Major advances in the care of HSV keratitis have been driven in large part by the landmark Herpetic Eye Disease Study randomized clinical trials, which were among the first in ophthalmology to reflect emerging trial conventions, including multicenter subject enrollment, double-masking, placebo controls, and a priori sample size determinations. The results of these trials now form much of the evidence basis for the management of this disease. However, management patterns in clinical practice often deviate from evidence-based care. These perceived quality gaps have given rise to the evolving field of implementation science, which is concerned with the methods of promoting the application of evidence-based medicine within routine care. To overcome variations in the quality and consistency of care for HSV keratitis, a range of clinical- and technology-based innovations are proposed. The most pressing needs include the following: a rational and tractable disease classification scheme that provides an immediate link between the anatomical localization of disease (corneal epithelial, stromal, or endothelial) and the appropriate treatment, and the actualization of an electronic medical record system capable of providing evidence-based treatment algorithms at relevant points of care. The latter would also input data to population-wide disease registries to identify implementation-rich targets for quality improvement, education, and research. These innovations may allow us to reduce the human and economic burdens of this highly morbid, and often blinding, disease.
- Published
- 2020
- Full Text
- View/download PDF
44. The Changing Global Epidemic of HIV and Ocular Disease.
- Author
-
Peters RPH, Kestelyn PG, Zierhut M, and Kempen JH
- Subjects
- AIDS-Related Opportunistic Infections drug therapy, Anti-Retroviral Agents therapeutic use, Antiretroviral Therapy, Highly Active, Eye Infections, Viral drug therapy, Global Health, HIV Infections drug therapy, Humans, Retinal Diseases drug therapy, AIDS-Related Opportunistic Infections epidemiology, Eye Infections, Viral epidemiology, HIV Infections epidemiology, Retinal Diseases epidemiology
- Abstract
Purpose : Overview of the evolving epidemiology of human immunodeficiency virus (HIV)-related ocular disease over time. Method : Narrative review. Results : HIV enhances susceptibility to opportunistic eye infections, has direct pathogenic effects, and places patients at risk of immune recovery inflammatory syndromes in previously infected eyes after starting highly-active antiretroviral therapy (HAART). Widespread availability of HAART has resulted in a decrease of infectious ocular conditions such as cytomegalovirus retinitis, toxoplasmic retinitis, squamous cell carcinoma of the conjunctiva, and microvascular retinopathy. However, large coexisting burdens of tuberculosis, herpesvirus infection and syphilis (among others) continue to contribute to the burden of ocular disease, especially in low-resource settings. Growing risks of cataract, retinopathy and retinal nerve fiber thinning can affect patients with chronic HIV on HAART; thought due to chronic inflammation and immune activation. Conclusion : The changing epidemic of ocular disease in HIV-infected patients warrants close monitoring and identification of interventions that can help reduce the imminent burden of disease.
- Published
- 2020
- Full Text
- View/download PDF
45. Covid-19, ocular manifestation and ophthalmic risks.
- Author
-
Joob B and Wiwanitkit V
- Subjects
- COVID-19, Coronavirus Infections transmission, Eye Infections, Viral transmission, Humans, Infectious Disease Transmission, Patient-to-Professional statistics & numerical data, Pandemics, Pneumonia, Viral transmission, SARS-CoV-2, Thailand epidemiology, Betacoronavirus, Coronavirus Infections epidemiology, Eye Infections, Viral epidemiology, Ophthalmologists, Pneumonia, Viral epidemiology
- Published
- 2020
- Full Text
- View/download PDF
46. A Review on 2019 Novel Coronavirus Pneumonia in Ophthalmology.
- Author
-
Bagheri M, Rashe Z, and Jafari A
- Subjects
- COVID-19, Coronavirus Infections epidemiology, Eye Infections, Viral epidemiology, Global Health, Humans, Incidence, Pneumonia, Viral epidemiology, SARS-CoV-2, Betacoronavirus, Coronavirus Infections complications, Eye Infections, Viral etiology, Ophthalmology, Pandemics, Pneumonia, Viral complications
- Abstract
Purpose: To investigate the possibility of ocular involvement in the 2019-novel coronavirus infectious (2019-nCoV) and vital preventive measures in the field of ophthalmology., Methods: All the studies that were most relevant to the 2019-nCoV ocular involvement and routes of transmission, especially in the field of ophthalmology, thoroughly reviewed., Results: From the ocular perspective, conjunctivitis may be the first presenting symptom of 2019-nCoV, so, we as ophthalmologists are at the forefront of exposure with newly infected patients. Although transconjunctival aerosol is a suspected but, the main route of transmission is the known respiratory droplets which will be more significant due to close contact in the field of ophthalmology. This review advise a set of recommendation for preventive care to minimize cross-infection of 2019-nCoV., Conclusions: Ophthalmologists have an essential role in guiding cross-infection control measures between patients and staff. Until a vaccine is created, public health strategies are likely the best weapons against this invisible enemy.
- Published
- 2020
- Full Text
- View/download PDF
47. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study.
- Author
-
Sindhuja K, Lomi N, Asif MI, and Tandon R
- Subjects
- Adolescent, Adult, Aged, COVID-19, Child, Child, Preschool, Conjunctivitis, Viral diagnosis, Coronavirus Infections diagnosis, Cross-Sectional Studies, Eye Infections, Viral diagnosis, Female, Humans, India epidemiology, Male, Middle Aged, Pandemics, Pneumonia, Viral diagnosis, Prevalence, Retrospective Studies, SARS-CoV-2, Tertiary Healthcare statistics & numerical data, Betacoronavirus, Conjunctivitis, Viral epidemiology, Coronavirus Infections epidemiology, Eye Infections, Viral epidemiology, Hospitals, Special statistics & numerical data, Ophthalmology statistics & numerical data, Pneumonia, Viral epidemiology
- Abstract
Purpose: To find the clinical profile and prevalence of conjunctivitis and other ocular manifestations in mild COVID-19 positive patients in a nodal COVID-19 hospital., Methods: A retrospective cross-sectional, single-center study conducted in 127 mild cases of COVID-19 positive patients admitted between 27
th March and 19th April 2020 in a tertiary care COVID-19 hospital in north India. From the hospital records, demographic data is collected. Ocular history and ocular examinations were done by face-to-face survey during ward rounds., Results: A total of 127 patients were included in the study with a median age of 38.8 years. Forty-eight (37.80%) patients had upper respiratory tract symptoms, 20 (15.75%) patients had systemic illness, 18 (14.17%) patients were using spectacles, and 50 (39.37%) patients had history of hand-eye contact. Out of 12 (9.45%) patients who had ocular complaints, 11 (8.66%) had ocular manifestation after admission. Among 11 patients, eight (6.29%) had conjunctival congestion. Three (3/8) patients had developed conjunctival congestion even before the manifestation of definite COVID-19 symptoms. Five patients (5/8) patients had no other associated ocular symptoms other than congestion. Six patients (6/8) had symptoms of upper respiratory tract infection., Conclusion: Mild conjunctivitis manifesting as conjunctival congestion is common and is one of the major ocular manifestations in COVID-19 positive patients even with milder disease., Competing Interests: None- Published
- 2020
- Full Text
- View/download PDF
48. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report.
- Author
-
Valente P, Iarossi G, Federici M, Petroni S, Palma P, Cotugno N, De Ioris MA, Campana A, and Buzzonetti L
- Subjects
- COVID-19 virology, Child, Child, Preschool, Conjunctiva virology, Eye Infections, Viral epidemiology, Female, Humans, Infant, Infant, Newborn, Male, Prospective Studies, COVID-19 epidemiology, Eye Infections, Viral virology, Pandemics, SARS-CoV-2 isolation & purification, Tears virology, Virus Shedding
- Abstract
Purpose: To evaluate ocular manifestations and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) prevalence in the tears of children with coronavirus disease 2019 (COVID-19)., Methods: A total of 27 pediatric patients with confirmed COVID-19 infection hospitalized from March 16 to April 15, 2020, at the Bambino Gesù Children's Hospital were enrolled in the study. At admission, all patients showed ocular manifestations. Reverse transcriptase-polymerase chain reaction from nasopharyngeal and conjunctival swabs were performed every 2-3 days before discharge., Results: Of the 27 patients, 4 (15%) were asymptomatic, 15 (56%) showed respiratory symptoms, and 8 (30%) had gastrointestinal symptoms. At admission, nasopharyngeal swabs were positive for COVID-19 in all patients; on the second swabs, 7 children (26%) tested negative, and 20 remained positive for COVID-19. Ocular manifestations consistent with mild viral conjunctivitis were observed in 4 patients (15%). At first conjunctival swab, 3 patients (11%), 1 symptomatic and 2 asymptomatic for ocular infection, had positive findings for COVID-19; 2 became negative on the second test and 1 on the third., Conclusions: In our study cohort, ocular manifestations of COVID-19 seem to have had a milder clinical course in pediatric patients than in adults. Despite the low prevalence and rapid regression of viral presence in the conjunctiva, SARS-CoV-2 transmission through tears may be possible, even in patients without apparent ocular involvement., (Copyright © 2020 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
49. Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran.
- Author
-
Abrishami M, Tohidinezhad F, Daneshvar R, Omidtabrizi A, Amini M, Sedaghat A, Amini S, Reihani H, Allahyari A, Seddigh-Shamsi M, Tayyebi M, Naderi H, Bojdy A, Khodashahi R, and Eslami S
- Subjects
- Adult, Aged, Aged, 80 and over, COVID-19, Conjunctivitis, Viral epidemiology, Coronavirus Infections epidemiology, Cross-Sectional Studies, Eye Infections, Viral epidemiology, Female, Hospitalization, Humans, Hyperemia diagnosis, Hyperemia epidemiology, Iran epidemiology, Male, Middle Aged, Pandemics, Pneumonia, Viral epidemiology, SARS-CoV-2, Slit Lamp Microscopy, Young Adult, Betacoronavirus pathogenicity, Conjunctivitis, Viral diagnosis, Coronavirus Infections diagnosis, Eye Infections, Viral diagnosis, Pneumonia, Viral diagnosis
- Abstract
Purpose: To evaluate ocular findings in patients with Coronavirus Disease 2019 (COVID-19) in the Northeast of Iran., Methods: In a cross-sectional, observational study all consecutive patients with confirmed COVID-19 diagnosis at the central referral center of these patients in northeast of Iran were included. Ocular examinations (external and slit) were randomly performed for the patients who were admitted to the Intensive Care Unit (ICU) and six COVID wards of the hospital. Moreover, Chart records and serum chemistry results were collected., Results: A total of 142 patients with the mean age of 62.6 ± 15 years (range: 23-96 years) and almost equal gender distribution (male: N = 77, 54.2%) were included in the study. During the initial external examination by the ophthalmologist, 44 (31%) patients were found to have conjunctival hyperemia and 22 (15.5%) patients had chemosis. Consecutive slit examination showed 41 (28.9%) conjunctival hyperemia, 22 (15.5%) chemosis, 11 (7.7%) cataract, and 9 (6.3%) diabetic retinopathy. The patients with at least one ocular manifestation had significantly higher blood urea levels at the time of admission compared to those with no obvious ocular involvement (median: 41.5, IQR: 28-66.3 vs. median: 33, IQR: 23.8-51.8, P = .023). Moreover, a significant difference was observed in the total white blood cell count, lymphocyte percent, neutrophil count, Erythrocyte Sedimentation Rate (ESR), and blood urea level between patients with positive and negative Polymerase Chain Reaction (PCR) for SARS-CoV-2 virus. None of the patients reported ocular symptoms prior to systemic involvement. The proportion of patients with at least one ocular manifestation was significantly higher in those admitted in the ICU compared to the non-ICU wards. wards. While conjunctival hyperemia was the most prevalent ocular finding in all patients, chemosis was the most common ocular manifestation in ICU admitted patients., Conclusion: Ocular manifestation was observed in more than half of our COVID-19 patients. Hence, it seems important to involve ophthalmologist in the diagnosis and management of these patients.
- Published
- 2020
- Full Text
- View/download PDF
50. COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations.
- Author
-
Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, and Agrawal R
- Subjects
- COVID-19, Conjunctivitis, Viral epidemiology, Coronavirus Infections epidemiology, Cross Infection transmission, Disease Outbreaks, Eye Infections, Viral epidemiology, Humans, Pandemics, Pneumonia, Viral epidemiology, SARS-CoV-2, Tears virology, Betacoronavirus isolation & purification, Conjunctivitis, Viral transmission, Coronavirus Infections transmission, Eye Infections, Viral transmission, Pneumonia, Viral transmission
- Abstract
Purpose: The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached pandemic proportions within an unprecedented span of time. It is controversial whether the virus can be transmitted via tears and its ocular implications have not been widely studied. In this article, the current evidence related to ocular transmission and ocular manifestations is reviewed., Results: Several mechanisms for the ocular transmission of the virus are proposed with highlight on the nasolacrimal system as a conduit between the eye and the respiratory tract, and the role of the lacrimal gland in hematogenous spread. Ocular surface manifestations such as conjunctivitis are more commonly reported., Conclusion: The exact pathophysiology of ocular transmission of the virus remains incompletely understood, although there is preliminary evidence of SARS-CoV-2 being detected in ocular secretions. The ocular tropism of the virus and its potential to cause localized ocular disease are worth considering.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.